PTC
HRMY icon

Petrus Trust Company’s Harmony Biosciences HRMY Stock Holding History

Petrus Trust Company’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,636
Closed -$210K – 82
2025
Q3 		$210K Sell
7,636
-8,761
-53% -$302K 0.02% 98
2025
Q2 		$518K Buy
16,397
+4,924
+43% +$158K 0.05% 106
2025
Q1 		$381K Buy
+11,473
New +$411K 0.04% 304
2023
Q4 		– Sell
-6,809
Closed -$223K – 662
2023
Q3 		$223K Sell
6,809
-4,067
-37% -$141K 0.02% 501
2023
Q2 		$383K Sell
10,876
-1,662
-13% -$57.4K 0.04% 264
2023
Q1 		$409K Buy
+12,538
New +$571K 0.05% 167

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Petrus Trust Company's HRMY Position: Q4 2025 in Review

Petrus Trust Company sold out of Harmony Biosciences (HRMY) in Q4 2025, closing a stake of 7,636 shares — an estimated $210K sold.

Petrus Trust Company first reported a position in HRMY in Q1 2023 and held it in 6 quarters. The position peaked at $518K in Q2 2025. 323 funds tracked by Wall St. Rank hold HRMY as of Q4 2025.

  • Petrus Trust Company reported no remaining Harmony Biosciences position as of Q4 2025 after selling out during the quarter.
  • Petrus Trust Company sold 7,636 Harmony Biosciences shares in Q4 2025, an estimated $210K.
  • Petrus Trust Company first reported a position in Harmony Biosciences in Q1 2023 and held it in 6 quarters.
  • Petrus Trust Company's Harmony Biosciences position peaked at $518K in Q2 2025.
  • 323 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2025.

Based on Petrus Trust Company's 13F filing for Q4 2025, filed 17 Feb 2026.